Kala Pharmaceuticals Inc. (KALA)
$2.30
$0.01
(0.44%)
As on 09-Jun-2026 13:26EDT
Market cap
$38 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
3.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-2.4 %
-
ROCE
-- %
-
Industry P/E
30.75
-
EV/EBITDA
-0.2
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-2.7
-
Face value
--
-
Shares outstanding
18,589,832
10 Years Aggregate
CFO
$-544.50 Mln
EBITDA
$-559.34 Mln
Net Profit
$-586.87 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Kala Pharmaceuticals (KALA)
| -91.7 | -42.0 | -83.5 | -98.9 | -85.5 | -80.5 | -- |
|
BSE Sensex
| -12.7 | -4.4 | -6.3 | -10.1 | 5.6 | 7.2 | 10.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Kala Pharmaceuticals (KALA)
| -92.0 | -0.9 | -81.7 | 26.1 | -82.2 | 83.7 | -24.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Kala Pharmaceuticals (KALA)
|
2.3 | 38.3 | 0.0 | -19.7 | -- | -- | -- | 3.9 |
| 41.0 | 5,252.7 | 1,105.3 | 133.3 | 15.9 | 32.7 | 38.3 | 12.7 | |
| 243.8 | 11,955.1 | 708.2 | -188.3 | -25.6 | -293.5 | -- | 218.2 | |
| 67.1 | 13,242.2 | 580.0 | -725.9 | -105.2 | -- | -- | 123.7 | |
| 75.8 | 7,795.9 | 769.1 | 47.9 | 5.4 | 7.5 | 207.5 | 12.2 | |
| 13.3 | 11,055.0 | 353,471.6 | 45,087.2 | 16.1 | 12.8 | 24.6 | 2.7 | |
| 24.4 | 11,876.9 | 4,893.0 | -242.0 | -1.5 | -3.7 | -- | 1.8 | |
| 7.4 | 5,199.6 | 7,447.6 | 415.6 | 16.2 | 6.6 | 10.8 | 0.8 | |
| 239.7 | 4,749.7 | 274.5 | 153.6 | 76.6 | 15.8 | 30.9 | 4.8 | |
| 63.7 | 5,500.2 | 288.1 | 22.3 | 17.5 | 34.1 | 363.8 | 51.2 |
Shareholding Pattern
View DetailsAbout Kala Pharmaceuticals (KALA)
KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic... AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agentic workflows on trial data. The company serves biotechnology and pharmaceutical companies. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts. Read more
-
Chairman & CEO
Mr. Mark T. Iwicki
-
Chairman & CEO
Mr. Mark T. Iwicki
-
Headquarters
Arlington, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Kala Pharmaceuticals (KALA)
What is the current share price of Kala Pharmaceuticals Inc (KALA) Today?
The share price of Kala Pharmaceuticals Inc (KALA) is $2.30 (NASDAQ) as of 09-Jun-2026 13:26 EDT. Kala Pharmaceuticals Inc (KALA) has given a return of -85.46% in the last 3 years.
What is the current PB & PE ratio of Kala Pharmaceuticals Inc (KALA)?
Since, TTM earnings of Kala Pharmaceuticals Inc (KALA) is negative, P/E ratio is not available.
The P/B ratio of Kala Pharmaceuticals Inc (KALA) is 3.85 times as on 05-Jun-2026, a 31 discount to its peers’ median range of 5.54 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-0.16
|
0.64
|
|
2024
|
-0.72
|
2.25
|
|
2023
|
-0.33
|
1.87
|
|
2022
|
-1.70
|
4.02
|
|
2021
|
-0.01
|
0.07
|
What is the 52 Week High and Low of Kala Pharmaceuticals Inc (KALA)?
The 52-week high and low of Kala Pharmaceuticals Inc (KALA) are Rs 1,030.00 and Rs 2.03 as of 10-Jun-2026.
What is the market cap of Kala Pharmaceuticals Inc (KALA)?
Kala Pharmaceuticals Inc (KALA) has a market capitalisation of $ 38 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Kala Pharmaceuticals Inc (KALA)?
Before investing in Kala Pharmaceuticals Inc (KALA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.